{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:31Z","timestamp":1761468871851,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.transci.2021.103179","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:04:31Z","timestamp":1622678671000},"page":"103179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Blood donor deferral periods after COVID-19 vaccination"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-4858","authenticated-orcid":false,"given":"Abhaykumar Malind","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2021","series-title":"WHO Interim guidance, February 2021; maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic","key":"10.1016\/j.transci.2021.103179_bib0005"},{"year":"2021","series-title":"United States Food and Drug Administration updated information for blood establishments regarding the COVID-19 pandemic and blood donation","key":"10.1016\/j.transci.2021.103179_bib0010"},{"year":"2021","series-title":"AABB summary: donation of CCP, blood components, and HCT\/Ps, including information on COVID-19 vaccines, treatment with CCP, or monoclonals","key":"10.1016\/j.transci.2021.103179_bib0015"},{"year":"2021","series-title":"Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee Change Notification No. 04 - 2021 Coronavirus Vaccination \u2013 Applies to the Whole Blood and Components Donor Selection Guidelines","key":"10.1016\/j.transci.2021.103179_bib0020"},{"year":"2021","series-title":"European Centre for Disease Prevention Control Technical report Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU\/EEA - second update","key":"10.1016\/j.transci.2021.103179_bib0025"},{"year":"2021","series-title":"Australian Red Cross lifeblood blood donation guidelines","key":"10.1016\/j.transci.2021.103179_bib0030"},{"year":"2021","series-title":"COVID-19 vaccine and blood donation guidelines","author":"Singapore Health Sciences Authority","key":"10.1016\/j.transci.2021.103179_bib0035"},{"year":"2021","series-title":"Canadian blood services guidelines","key":"10.1016\/j.transci.2021.103179_bib0040"},{"year":"2021","series-title":"The Abu Dhabi Health Services Company statement","key":"10.1016\/j.transci.2021.103179_bib0045"},{"year":"2021","series-title":"The National Blood Transfusion Council (India) blood donation guidelines","key":"10.1016\/j.transci.2021.103179_bib0050"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:52:19Z","timestamp":1761468739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1473050221001452"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103179","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood donor deferral periods after COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103179"}}